Nicotinamide Riboside for Physical / metabolic function and Nicotinamide Riboside
Each entry’s own grades, side by side. A grade says how strong the evidence is for one outcome — it does not rank one entry over the other.
Evidence brief
Nicotinamide Riboside for Physical / metabolic function
Evidence grade C — Inconsistent
Grade C1 graded outcomerevised Jul 10, 2026
Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.
Compound or practice
Nicotinamide Riboside
The better-studied NAD+ precursor — reliably raises NAD+, still short on hard human outcomes.
Grade C2 graded outcomesrevised Jul 10, 2026
A structured monograph in Prometheus's bundled library. Its grades are the monograph's own reading of the evidence, not a peer-reviewed review.
Graded in both
Outcomes are matched by name. Two entries can describe the same outcome in different words, so one listed further down may still be graded in the other.
| Outcome | Nicotinamide Riboside for Physical / metabolic function | Nicotinamide Riboside |
|---|---|---|
| Physical / metabolic function | Evidence grade CSmall effectmixedInconsistent | Evidence grade CSmall effectmixedInconsistent |
Graded only in Nicotinamide Riboside for Physical / metabolic function
None — every outcome it grades is graded in both.
Graded only in Nicotinamide Riboside
- Blood NAD+ Moderate effectEvidence grade A
What each entry says about the other
- Nicotinamide Riboside for Physical / metabolic function’s entry · Goes with: Read the full Nicotinamide Riboside monograph
Both columns are read from the entries as they stand in this library. A comparison is not advice to take either one, and it is no substitute for a clinician who knows the person.